South Dakota Investment Council’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,771
Closed -$502K 649
2020
Q4
$502K Sell
1,771
-1,200
-40% -$337K 0.01% 518
2020
Q3
$817K Sell
2,971
-400
-12% -$106K 0.02% 439
2020
Q2
$766K Sell
3,371
-4,800
-59% -$943K 0.02% 433
2020
Q1
$1.24M Buy
8,171
+4,171
+104% +$642K 0.03% 336
2019
Q4
$601K Hold
4,000
0.01% 474
2019
Q3
$567K Hold
4,000
0.01% 513
2019
Q2
$501K Hold
4,000
0.01% 507
2019
Q1
$441K Hold
4,000
0.01% 509
2018
Q4
$392K Hold
4,000
0.01% 510
2018
Q3
$494K Buy
+4,000
New +$449K 0.01% 507

Other funds holding WST

South Dakota Investment Council's WST Position: Q1 2021 in Review

South Dakota Investment Council sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 1,771 shares — an estimated $502K sold.

South Dakota Investment Council first reported a position in WST in Q3 2018 and held it in 10 quarters. The position peaked at $1.24M in Q1 2020. 591 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • South Dakota Investment Council reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 1,771 West Pharmaceutical shares in Q1 2021, an estimated $502K.
  • South Dakota Investment Council first reported a position in West Pharmaceutical in Q3 2018 and held it in 10 quarters.
  • South Dakota Investment Council's West Pharmaceutical position peaked at $1.24M in Q1 2020.
  • 591 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on South Dakota Investment Council's 13F filing for Q1 2021, filed 13 May 2021.